Jean-max Pasquet

Bordeaux, France

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 24 publications

Dual targeting of CDK6 and LSD1 is synergistic and overcomes differentiation blockade in AML.

Dual targeting of CDK6 and LSD1 is synergistic and overcomes differentiation blockade in AML.

Journal: EMBO molecular medicine
Published: October 18, 2024

Autophagy Targeting and Hematological Mobilization in FLT3-ITD Acute Myeloid Leukemia Decrease Repopulating Capacity and Relapse by Inducing Apoptosis of Committed Leukemic Cells.

Autophagy Targeting and Hematological Mobilization in FLT3-ITD Acute Myeloid Leukemia Decrease Repopulating Capacity and Relapse by Inducing Apoptosis of Committed Leukemic Cells.

Journal: Cancers
Published: November 30, 2021

Protein Kinases in Leukemias.

Protein Kinases in Leukemias.

Journal: Cancers
Published: May 26, 2021

α-Tocopherol Attenuates Oxidative Phosphorylation of CD34+ Cells, Enhances Their G0 Phase Fraction and Promotes Hematopoietic Stem and Primitive Progenitor Cell Maintenance.

α-Tocopherol Attenuates Oxidative Phosphorylation of CD34+ Cells, Enhances Their G0 Phase Fraction and Promotes Hematopoietic Stem and Primitive Progenitor Cell Maintenance.

Journal: Biomolecules
Published: February 23, 2021

α-Tocopherol Acetate Attenuates Mitochondrial Oxygen Consumption and Maintains Primitive Cells within Mesenchymal Stromal Cell Population.

α-Tocopherol Acetate Attenuates Mitochondrial Oxygen Consumption and Maintains Primitive Cells within Mesenchymal Stromal Cell Population.

Journal: Stem cell reviews and reports
Published: December 17, 2020

Dual Inhibition of FLT3 and AXL by Gilteritinib Overcomes Hematopoietic Niche-Driven Resistance Mechanisms in FLT3-ITD Acute Myeloid Leukemia.

Dual Inhibition of FLT3 and AXL by Gilteritinib Overcomes Hematopoietic Niche-Driven Resistance Mechanisms in FLT3-ITD Acute Myeloid Leukemia.

Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: August 07, 2020

Downregulation of Glutamine Synthetase, not glutaminolysis, is responsible for glutamine addiction in Notch1-driven acute lymphoblastic leukemia.

Downregulation of Glutamine Synthetase, not glutaminolysis, is responsible for glutamine addiction in Notch1-driven acute lymphoblastic leukemia.

Journal: Molecular oncology
Published: July 24, 2020

The Expression of Myeloproliferative Neoplasm-Associated Calreticulin Variants Depends on the Functionality of ER-Associated Degradation.

The Expression of Myeloproliferative Neoplasm-Associated Calreticulin Variants Depends on the Functionality of ER-Associated Degradation.

Journal: Cancers
Published: October 31, 2019

Increase in subjective well-being and psychological health after application of C8-silk lipoamino acid functionalized pigments included in a foundation.

Increase in subjective well-being and psychological health after application of C8-silk lipoamino acid functionalized pigments included in a foundation.

Journal: International journal of cosmetic science
Published: July 12, 2019

Targeting Tyrosine Kinases in Acute Myeloid Leukemia: Why, Who and How?

Targeting Tyrosine Kinases in Acute Myeloid Leukemia: Why, Who and How?

Journal: International journal of molecular sciences
Published: June 21, 2019

Killer immunoglobulin-like receptor genotypes and chronic myeloid leukemia outcomes after imatinib cessation for treatment-free remission.

Killer immunoglobulin-like receptor genotypes and chronic myeloid leukemia outcomes after imatinib cessation for treatment-free remission.

Journal: Cancer medicine
Published: May 02, 2019

Hematopoietic niche drives FLT3-ITD acute myeloid leukemia resistance to quizartinib via STAT5-and hypoxia-dependent upregulation of AXL.

Hematopoietic niche drives FLT3-ITD acute myeloid leukemia resistance to quizartinib via STAT5-and hypoxia-dependent upregulation of AXL.

Journal: Haematologica
Published: September 12, 2018
Showing 1-12 of 24

Last Updated: 09/26/2026